524743 — Fischer Medical Ventures Balance Sheet
0.000.00%
- IN₹21.87bn
- IN₹22.64bn
- IN₹3.09bn
Annual balance sheet for Fischer Medical Ventures, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.443 | 0.408 | 410 | 2,514 | 315 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 1.71 | 229 | 1,042 | 2,889 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.493 | 2.48 | 704 | 3,653 | 4,176 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | 125 | 197 | 293 |
| Net Goodwill | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1.9 | 3.54 | 863 | 4,574 | 6,710 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.2 | 6.2 | 38.3 | 1,018 | 2,580 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.2 | 6.2 | 52.1 | 1,198 | 2,866 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.29 | -2.66 | 811 | 3,375 | 3,844 |
| Total Liabilities & Shareholders' Equity | 1.9 | 3.54 | 863 | 4,574 | 6,710 |
| Total Common Shares Outstanding |